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Hemophilia is a hereditary bleeding disorder which requires lifelong specialized care.
A network of Hemophilia Treatment Centers (HTCs) exists to meet the medical needs of
patients affected by hemophilia. Genetic counseling services are an integral part of the HTC
model of care; however, many HTCs do not have genetic counselors on staff. As a result, the
duty to provide these services must fall to other healthcare providers within the HTC. To assess
the knowledge and attitudes of these providers we developed a 49 question survey that was
distributed electronically to hematologists and nurses at U.S. HTCs. The survey consisted of a
three sections: demographic information, knowledge of hemophilia genetics, and attitudes
towards genetic services. A total of 111 complete responses were received and analyzed. The
average knowledge score among all participants was 74.8% with a total of 81 participants
receiving a passing score of 70% or above. Thirty participants scored below 70% in the
knowledge section. In general, attitude scores were high indicating that the majority of
hematologists and nurses in HTCs feel confident in their ability to provide genetic counseling
services. Over 90% of participants reported that they have some form of access to genetic
counseling services at their center.
Hematologists and nurses practicing in U.S. HTCs demonstrate sufficient knowledge of
the genetics of hemophilia, and they generally feel confident in their ability to provide genetic
counseling services to their patients. While their knowledge is sufficient, the average
knowledge score was lower than 75%. Certain questions covering new genetic technologies
and testing practices were more commonly missed than questions asking about more basic
aspects of hemophilia genetics, such as inheritance and carrier testing. Finally, many clinics
report having access to a counselor, but it is oftentimes a hematologist or nurse who is
providing genetic counseling services to patients. Given the inconsistency in knowledge among
providers coupled with the high confidence in one’s ability to counsel patients, it leaves room to
question whether information about the genetics of hemophilia is being communicated to
patients in the most appropriate and accurate manner.
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Background

Hemophilia is a rare hereditary bleeding disorder characterized by a deficiency of either
coagulation factor VIII or IX with bleeding symptoms that range in severity from mild to severe
(1). Complications associated with hemophilia include hemarthrosis, hematomas of the soft
tissues, intracranial hemorrhages, prolonged bleeding, poor wound healing, prolonged oozing
following minor injuries, epistaxis, and ecchymosis (2). Due to the chronic nature and
specialized treatment of the disorder, the Health Resources and Services Administration
(HRSA) began funding a network of Hemophilia Treatment Centers (HTCs) in 1975 which
employ a multidisciplinary approach to the management of hemophilia (3).
There are over 140 registered HTCs across the United States (4) and each center is
comprised of a core staff that includes a medical director, nurse coordinator, psychosocial
professional, and physical therapist. Some centers have additional providers on staff such as
genetic counselors, orthopedists, and dentists (3). The goals of HTCs are outlined by both the
HRSA include: the provision of comprehensive care to patients and families affected by
hereditary bleeding disorders, such as hemophilia; the provision of services to women,
minorities, adolescents, the uninsured/underinsured, and people living in geographically
underserved regions; the provision of outreach and education services; education emphasizing
the importance of prevention of bleeding episodes; collaboration with other healthcare entities;
and connection of patients to primary care physicians. The Centers for Disease Control and
Prevention (CDC) performs surveillances of outcomes and monitors blood safety in patients
with hemophilia seen at HTCs.
HTCs rely on a multidisciplinary approach to patient management which incorporates
diagnosis, treatment, prevention and family education into its model of care. HTCs provide
healthcare services to 70-80% of individuals with hemophilia in the United States; and, in 2004,
27,662 patients received services from HTCs in the United States, 15,224 of whom had
hemophilia (5).
Genetic counseling services are an essential component of the multidisciplinary care for
patients with hemophilia. Genetic counseling services at HTCs mainly consist of genetic
education about the etiology, inheritance, recurrence risk, carrier screening, and genetic testing
of hemophilia. Among the 142 registered HTCs, the CDC reports that only 12 (8.5%) centers
have a genetic counselor on staff (4). Without a genetic counselor, the responsibility of
providing genetic education to patients would likely fall to a physician, nurse, or social worker
at the center.
While several studies have assessed the knowledge and attitudes of healthcare providers
toward genetic services, (6-11) there are no studies that have measured the genetics knowledge
9

of physicians and nurses in HTCs. The objective of this study is to determine the level of
genetics knowledge among physicians and nurses in HTCs, assess how genetic education is
being provided to patients, and identify the attitudes towards and barriers for patients
surrounding genetic counseling services in HTCs.

Materials and Methods

We developed a questionnaire, with permission, that was modeled after a validated tool
originally created by Hofman et al. and used to assess the knowledge of genetics and genetic
testing among family medicine physicians practicing in the United States (7). The questionnaire
used in this study was estimated to take 15-20 minutes to complete and was comprised of 49
questions divided into three sections: 1) demographic information (14 questions), 2) knowledge
of hemophilia genetics (14 questions), and 3) attitudes towards genetic services in an HTC (21
questions). The knowledge section consisted of multiple choice and true/false questions
covering subjects such as heredity, genetic testing, prenatal/reproductive issues, and carrier
screening as they apply specifically to hemophilia A. In addition, an optional free response
section was provided at the end of the questionnaire for participants who wished to include
other comments. The questionnaire was generated using the web-based REDCap software (12),
and it was only available in electronic format. The questionnaire and study design were
approved by the Committee for the Protection of Human Subjects (CPHS) at the University of
Texas Health Science Center in Houston, Texas prior to data collection.
Requests for survey participation were sent by email to hematologists and nurses in
U.S. HTCs. Email addresses for potential participants were obtained from the online HTC
Directory maintained by the CDC. In total, 570 email addresses were obtained from the
directory. Only email addresses for individuals listed as pediatric and/or adult hematologists,
nurses, and nurse practitioners in the directory were used. Of the 570 email addresses, 45 were
returned as undeliverable. In addition, 9 healthcare providers requested to be excluded from the
study. As a result, the total number of invited participants was 516.
Data collection occurred between September 2012 and February 2013. All responses
were submitted anonymously, and there were no incentives offered to survey participants.
Complete survey responses were compiled and analyzed in STATA statistical software (version
10, College Station, TX). Following completion of the questionnaire, individual participants
were given a knowledge score based on their responses in the knowledge section. Scores were
generated by calculating the number of correct responses divided by the total number of
questions. In the attitudes section, participants ranked their response using a 5 point Likert
scale with 1 representing those who strongly disagree and 5 representing those who strongly
10

agree. For the purposes of analysis Likert scale responses were grouped together into three
categories: 1-2, 3, and 4-5 which correspond to the thematic categories: 1)Disagree 2)Agree
3)Strongly agree. Similar categorization was done for the second part of the attitude section
where Likert responses were grouped together into three categories: 1-2, 3, and 4-5 which
correspond to the thematic categories: 1)Not confident 2)Neither confident nor unconfident
3)Confident. Comparisons between demographic features and knowledge and attitudes were
made using chi-square and one-sided t-tests. A cut-off p-value of 0.05 or less was used to
determine statistical significance. Overall demographic characteristics and study findings that
were statistically significant are reported.

Results

A total of 117 complete responses and 27 partial responses were received for an overall
response rate of 22.7%. This is comparable to response rates in similar studies (9,11). Partial
responses were excluded from the analysis. Of the 117 complete responses, 4 were from
genetic counselors and 2 were from other allied healthcare professionals. These responses were
analyzed separately since they were not part of the targeted population. Of the remaining 111
complete responses, 51 (46.0%) were from hematologists and 60 (54.1%) were from nurses.
Overall, there were 27 male participants (25.5%) and 79 female participants (74.5%) with an
average age of 60.0 years among the total cohort. Other demographic characteristics are
summarized in Table 1.
A total knowledge score was generated for each participant by dividing the correct
number of responses by the total number of questions with the highest possible score being 14
out of 14. The average score among all participants was 10.5 out of 14 (74.8%). A minimum
of 10 correct responses was required to achieve a passing score. All questions were weighted
equally. A total of 81 participants (73.0%) passed the knowledge section with a score of 70%
or higher and 30 participants (27.0%) scored below 70% in the knowledge section. Thirty-eight
out of 51 (74.5%) physicians and 43 out of 61 (71.7%) nurses achieved passing scores of 10 out
of 14 (71.4%) or more. The difference in pass rates between physicians and nurses (see Table
2) was not statistically significant (p = 0.737).
While the overall scores were not significantly different between physicians and nurses
there were three questions for which the correct response rate was significantly different
between the two groups. Question 1, which asked about the detection rate of F8 genetic testing
in males with severe hemophilia, and question 11, which asked about the best method for
determining whether or not a female is a carrier of hemophilia, were more frequently missed by
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nurses than physicians. Alternatively, question 10, which asked about the risk of recurrence for
a family with a simplex case, was more frequently missed by the physician group (Table 3).
Although knowledge scores were favorable overall, some topics were commonly
missed in this section by both physicians and nurses. Specifically, three questions were
consistently answered incorrectly by over 50% of the study population: questions 4, 6, and 14
(see Table 4). These questions covered topics including: preimplantation genetic diagnosis
(PGD), inheritance, and genetic testing.
The attitudes section consisted of two parts. In the first part participants were asked
about their attitudes regarding genetic counseling services in clinical practice. The statements
in this section covered subjects including the provider’s perceived value of genetic counseling
services, the provider’s comfort level with respect to certain aspects of genetic counseling
services, and referral practices. The breakdown of questions is summarized in Table 5.
Question 4, which focused on provider referral practices, indicated that physicians (60.8%)
were much more likely to refer patients for genetic counseling compared with nurses (36.7%, p
= 0.027).
The second part of the attitudes section asked participants how confident they felt about
providing individual aspects of genetic counseling services. Specifically, these questions
included details regarding genetic testing, psychosocial counseling, and insurance issues.
Participants ranked how confident they felt in their ability to provide information about these
topics using a 5 point Likert scale where 1 was not at all confident and 5 was very confident.
The results from this section are summarized in Table 6. Only question 13 showed a
statistically significant difference in responses between physicians and nurses. Responses to
this question demonstrated that physicians feel more confident than nurses in their ability to
discuss insurance issues that may arise in the context of genetic testing (p = 0.026).
Finally, a comparison of knowledge and attitude questions which covered the same
themes was performed. There were three major themes present in both the knowledge and
attitudes sections: inheritance, genetic testing, and carrier testing. Specifically, among
providers that incorrectly answered question 6, which asked about the risk of recurrence for a
carrier female, 79.0% agreed with the statement, “I feel comfortable educating a patient about
X-linked inheritance” (p = 0.393). Also, 57.6% of providers who incorrectly answered question
14, which asked about the best individual to offer genetic testing, agreed with the statement, “I
would feel comfortable explaining the benefits and limitations of genetic testing for
hemophilia” (p = 0.052). In addition, 72.7% of providers who incorrectly answered question 14
felt confident in their ability to help a patient decide whether to be tested (p = 0.748).
Lastly, our study assessed the type of access HTCs have to genetic counseling services.
The majority of participants (91.6%) reported that they have some form of access to genetic
12

counseling services at their center. A follow-up question gave participants the ability to specify
what type of access they have (see Table 7). The most common form of access reported was
having a genetic counselor that was available as needed (34.7%). Another 24.5% reported
having a genetic counselor that attends every clinic. Still, another 28.6% of participants
reported having other types of access. Participants who selected other were asked to specify
their access. Responses were categorized and are presented in Box 1. The most common form
of access specified by participants was a referral to a separate clinic outside of the HTC
(84.4%). Many of these clinics are within the same institution as the HTC, but a separate
appointment must be made. Also of note, the majority of providers (n = 83, 75.5%) agreed that
their patients would benefit from meeting with a genetic counselor as part of their care.

Box 1 Other forms of access to genetic
counseling services
By referral within institution (75.0%)
By referral outside of institution (9.4%)
Services provided by other healthcare providers,
not genetic counselors (9.4%)
Limited access/vacancies (6.3%)

Discussion

This study provides a glimpse into the level of knowledge and the attitudes of providers
in HTCs across the United States. The majority of providers have knowledge scores that
demonstrate an above average level of understanding of the genetics of hemophilia. In addition,
the majority of providers report that they feel comfortable providing basic genetic counseling
services to patients treated at HTCs. However, newer genetic technologies, such as
preimplantation genetic diagnosis (PGD), and issues of insurance discrimination are areas in
which providers not specifically trained in genetic counseling feel less comfortable.

Knowledge

When asked about PGD, the majority of physicians and nurses (59.5%) incorrectly
believed that PGD can be useful even if the familial gene mutation is not known. By
definition, PGD is used to detect the presence or absence of a mutated gene that is known to
13

cause a genetic disease in a single cell isolated from an embryo (13). Without having the
known familial mutation it is not possible to diagnose an embryo prior to implantation. That
being said, PGD is a specialized service that is not considered standard of care for patients with
hemophilia. As a result, it is reasonable to say that complex issues in genetic medicine, such as
PGD, lie outside the scope of practice of hematologists and nurses in HTCs; and, therefore, the
discussion of such issues with patients fall to other specially trained healthcare providers. Of
note, 3 out of the 4 genetic counselors that completed the survey answered this question
correctly. Out of all of the healthcare providers in HTCs it would seem most likely that patients
wishing to discuss PGD further should be referred to a genetic counselor when available.
Another question that was commonly answered incorrectly asked about the chance that,
in any given pregnancy, a female carrier would have a male with hemophilia. The majority
(55.9%) of participants answered incorrectly with the majority selecting 1 in 2 live births as
their answer. The correct response is 1 in 4 live births which takes into account both the chance
for a male baby that also inherits the disease-causing hemophilia mutation. It is possible that
responders made the assumption that the affected fetus is male, and thus selected the answer
choice that corresponded to the 50-50 chance in each pregnancy of a carrier female giving birth
to a male with hemophilia. It is likely that this is the case since the majority of participants
answered the other questions concerning the heredity of hemophilia correctly. By comparison,
though, all four of the genetic counselors that responded answered this question correctly.
While there is most likely not a deficiency in provider knowledge in regards to the inheritance
of hemophilia, it is important for providers to accurately communicate the risk of recurrence of
hemophilia to carrier females.
Lastly, the question which was answered incorrectly most often (61.3%) was question
14 in the knowledge section. This question asked which family member would be the best
person to offer genetic testing. It is generally agreed that, whenever possible, genetic testing
should only be offered if the results of the test can be adequately interpreted. For that reason it
is best to begin testing in an affected individual (or index case) before proceeding to test
seemingly unaffected family members in order to eliminate the possibility of receiving an
uninformative negative test result (14,15). In our study, the majority of physicians (52.9%) and
nurses (50.9%) did not choose to offer genetic testing to an affected individual first, but rather
chose to offer it to the sister of an affected male. While there is a 50% chance that this
individual could be a carrier, knowing the affected son’s genetic mutation would be important
to avoid the possibility of an uninformative negative test result in the sister. Another 7.8% of
physicians and 8.8% of nurses chose the mother of an affected son as the best candidate for
testing. Offering genetic testing to the mother poses the same risk to receive an uninformative
negative test result as with the sister of an affected male. Only after the causative mutation in
14

the family has been identified can genetic screening to other family members, whether they be
unaffected relatives or obligate carriers, be most informative. It is worthwhile to point out that
all four genetic counselors in the study chose to offer testing to the affected individual first. Our
finding is not surprising, and similar studies have demonstrated a lack of consistency in the
practices of providers in the context of genetic testing in individuals with a family history of a
genetic condition. For example, a study performed by Mehnert et al. found that approximately
50% of the gynecologists they surveyed did not recognize the importance of having the genetic
test results of an index patient when interpreting the test results of an unaffected individual (11).
Without confirmation of a known familial mutation, negative genetic testing in an unaffected
individual is not informative because it cannot rule out the possibility of an inherited mutation
that was undetectable by the testing methodology used.

Attitudes

Our study aimed to determine the attitudes of providers toward genetic counseling
services as well as their overall level of confidence in providing these services to patients.
Previously, a study by Hunter et al. showed that the majority of Canadian physicians felt that
they possessed adequate genetic knowledge; however, less than 50% of them felt comfortable
discussing information about genetic services with their patients (6). Since healthcare providers
working in HTCs see a large number of patients with hereditary bleeding disorders we wanted
to assess their attitudes toward educating patients about genetics. Overall, attitude scores
among physicians and nurses in our study were high indicating that most hematologists and
nurses in HTCs feel confident their ability to provide genetic counseling services. Questions in
this section focused on common aspects of hemophilia genetics such as counseling a patient
about genetic testing and helping a patient decided whether or not to pursue genetic testing.
Other attitude questions aimed to identify the provider’s perceived value of genetic counseling
services. The majority of participants indicated that they see value in genetic counseling
services, especially for first-degree female relatives of affected males.
In general, physicians felt more comfortable discussing possible insurance implications
with patients than nurses did. A study by Acton et al. found that 79% of physicians (family
practitioners, general internists, obstetrician-gynecologists) felt as though the information
obtained from genetic testing could be used by employers and insurance companies to
discriminate against people who had an increased risk for a hereditary cancer (9). We
hypothesized that a similar attitude may be present in HTCs since many patients, particularly
potential carriers, are concerned that having genetic testing will result in insurance
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discrimination, in the form of increased premiums or gap in coverage due to a pre-existing
condition.
Comparison of knowledge and attitude questions addressing the same theme revealed
discordance between provider knowledge and perception of ability to provide a specific genetic
counseling service. While not statistically significant these results illustrate the dilemma that
arises when providers inaccurately educate/counsel patients when they believe that they are
providing the correct information. Specifically, question 13 in the knowledge section asked
providers to identify an obligate carrier in a pedigree. This question was compared to the
provider’s response to the statement: I feel comfortable educating my patient about X-linked
inheritance. Twelve out of the 16 (75.0%) providers who incorrectly identified an obligate
female carrier, somewhat to strongly agreed that they were comfortable discussing inheritance
with a patient. This highlights an inconsistency in the accuracy of the information being
delivered by providers and their recognition of their own abilities. Two other hereditary
questions produced similar results (questions 7 and 9 in the knowledge section) when compared
to the provider’s attitude toward discussing heredity with a patient.

Limitations

Despite our best efforts, this study had a few limitations which must be considered.
One significant limitation of this study is that it was only distributed to physicians and nurses
whose email addresses were listed in the CDC’s online directory. This directory does not
include the contact information for every provider in every center nationwide, and therefore this
sample is biased by the fact that it was selectively distributed to providers listed in the directory.
Also, the number of complete responses is not sufficiently large to produce results with a high
statistical power. In addition this study lacked a validated instrument. Even though our tool
was modeled after the survey developed and validated by Hofman et al. in the 1990s, it was not
validated prior to use in the hemophilia community. As a result, some of the incorrect
responses may not indicate a deficit of knowledge, but rather a misinterpretation of the question
or answer choices.

Future Directions

While this study provides a snapshot of the knowledge and attitudes of hematologists
and nurses in U.S. HTCs it does not provide insight into the knowledge and attitudes of genetic
counselors or other providers who are affiliated with HTCs. Based on the results of our
questionnaire, the majority of providers (91.6%) report having access to genetic counseling
16

services via a genetic counselor; however, not every HTC has a genetic counselor working on
site. A follow-up study assessing the knowledge and attitudes of genetic counselors providing
genetic counseling services to patients affected by hemophilia would be beneficial to further
refine the understanding of the level of service available to patients at U.S. HTCs.

Conclusion

Hematologists and nurses practicing in U.S. HTCs demonstrate sufficient knowledge of
the genetics of hemophilia, and they generally feel confident in their ability to provide genetic
counseling services to their patients. While their knowledge is sufficient, the average
knowledge score was lower than the 75% that we had anticipated. In addition, approximately
23% of physicians and nurses did not demonstrate sufficient knowledge of hemophilia genetics
in our study. Based on these findings, there is room for improvement in the genetics education
of providers working in HTCs. Interestingly, there is no significant difference in the knowledge
or attitudes between hematologists and nurses in HTCs; however, there is evidence to suggest
that there are some topics that physicians feel more comfortable discussing with their patients
than nurses do. In addition, level of knowledge has no effect on a provider’s level of
confidence in providing genetic counseling services. Finally, many clinics report having
“access” to a counselor, but the reality is that in clinic, it is oftentimes the nurse or physician
who is providing genetic counseling services to patients. Given the inconsistency in provider
knowledge coupled with the high confidence in one’s ability to counsel patients, it leaves room
to question whether information about the genetics of hemophilia is being communicated to
patients in the most appropriate and accurate manner.
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Appendix:
Table 1: Summary of demographic characteristics of study population
Characteristic

n

Age
20-29 years
30-39 years
40-49 years
50-59 years
60+ years
Gender
Male
Female
Not disclosed
Patient Population
Adult
Pediatric
Both
Not disclosed
Certified
Yes
No
I don't know or N/A
Years of HTC experience
Less than 1 year
1-5 years
5-10 years
10-20 years
More than 20 years
Not disclosed
Average size of patient population
Less than 50 patients
50-100 patients
100-200 patients
More than 200 patients
Not disclosed

Physicians
%

n

Nurses
%

0
7
13
19
12

0.00%
13.73%
25.49%
37.25%
23.53%

5
8
11
29
7

8.33%
13.33%
18.33%
48.33%
11.67%

24
25
2

47.06%
49.02%
3.92%

3
54
3

5.00%
90.00%
5.00%

12
20
16
3

23.53%
39.22%
31.37%
5.88%

6
16
38
0

10.00%
26.67%
63.33%
0.00%

47
3
1

92.16%
5.88%
1.96%

16
31
13

26.67%
51.67%
21.67%

0
7
11
18
14
1

0.00%
13.73%
21.57%
35.29%
27.45%
1.96%

4
15
6
21
14
0

6.67%
25.00%
10.00%
35.00%
23.33%
0.00%

4
20
17
9
1

7.84%
39.22%
33.33%
17.65%
1.96%

14
21
15
9
1

23.33%
35.00%
25.00%
15.00%
1.67%

Table 2: Pass Rates by provider type
Score
Pass
Fail

Physician
Nurse
n
%
n
%
38
74.51% 43
71.67%
13
25.49% 17
28.33%
18

Table 3: Summary of knowledge section, by provider type
Question (correct
answer)
1. Genetic testing of the F8 gene
detects mutations in what
percentage of men with severe
Hemophilia A? (80-100%)
2. Which genetic test is most likely
to be informative in a male with
severe hemophilia A? (Factor VIII
intron 22 inversion analysis)
3. Prenatal diagnosis is most
informative when a familial gene
mutation is known. (True)
4. Preimplantation genetic diagnosis
can be useful even if the familial
gene mutation is not known (False)
5. A female with normal factor VIII
level (70-140%) cannot be a carrier
(False)
6. The chance of a couple having a
boy with hemophilia if the mother is
a carrier is: (1 in 4 live births)
7. The chance of a couple having a
boy with hemophilia if the father
has hemophilia and the mother is
not a carrier is: (None of the above)
8. An 8 year old boy with
hemophilia A comes into clinic with
his mother and 4 year old sister.
The sister had a blood test which
revealed a factor level of 60%.
What do you tell the mother about
her daughter? (There is no way to
know . . .)
9. A boy is diagnosed with severe
hemophilia after developing
bleeding symptoms. Genetic testing
for this boy revealed an intron 22
inversion mutation in the F8 gene.
The chance that his mother is a
carrier for hemophilia is: (90-100%)
10. If one boy in a family has
hemophilia but he has no other
family members with bleeding
symptoms, the chances that the next
son of the same parents will have
hemophilia is: (50%)
11. In order to determine a female's
carrier status one should order:
(Both factor level and genetic
testing)
12. In an X-linked condition: (50%
of the daughters of female carriers
will be carriers)
13. Which female family members
are obligate carriers? (Individual II2 only)
14. Which person in this family
would be the best candidate to offer
genetic testing? (Individual III-1)

Physician
Correct
Incorrect
n
%
n
%

Nurse
Correct
Incorrect
n
%
n
%

38

74.51%

13

25.49%

32

53.33%

28

46.67%

0.021

39

76.47%

12

23.53%

43

71.67%

17

28.33%

0.566

48

94.12%

3

5.88%

58

96.67%

2

3.33%

0.660

20

39.22%

31

60.78%

25

41.67%

35

58.33%

0.793

49

96.08%

2

3.92%

60

100.00%

0

0.00%

0.209

26

50.98%

25

49.02%

23

38.33%

37

61.67%

0.181

49

96.08%

2

3.92%

59

98.33%

1

1.67%

0.593

45

88.24%

6

11.76%

58

96.67%

2

3.33%

0.140

37

72.55%

14

27.45%

40

66.67%

20

33.33%

0.503

35

68.63%

16

31.37%

52

86.67%

8

13.33%

0.021

42

82.35%

9

17.65%

39

65.00%

21

35.00%

0.040

49

96.08%

2

3.92%

58

96.67%

2

3.33%

1.000

45

88.24%

6

11.76%

50

83.33%

10

16.67%

0.464

20

39.22%

31

60.78%

23

38.33%

37

61.67%

0.924

P-value
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Table 4: Summary of knowledge section
Question (correct answer)

Correct

Incorrect
n
%

n

%

1. Genetic testing of the F8 gene detects mutations in what
percentage of men with severe Hemophilia A? (80-100%)

70

63.06%

41

36.94%

2. Which genetic test is most likely to be informative in a male
with severe hemophilia A? (Factor VIII intron 22 inversion
analysis)

82

73.87%

29

26.13%

3. Prenatal diagnosis is most informative when a familial gene
mutation is known. (True)

106

95.50%

5

4.50%

4. Preimplantation genetic diagnosis can be useful even if the
familial gene mutation is not known (False)

45

40.54%

66

59.46%

5. A female with normal factor VIII level (70-140%) cannot be a
carrier (False)

109

98.20%

2

1.80%

6. The chance of a couple having a boy with hemophilia if the
mother is a carrier is: (1 in 4 live births)

49

44.14%

62

55.86%

108

97.30%

3

2.70%

103

92.79%

8

7.21%

77

69.37%

34

30.63%

10. If one boy in a family has hemophilia but he has no other
family members with bleeding symptoms, the chances that the
next son of the same parents will have hemophilia is: (50%)

87

78.38%

24

21.62%

11. In order to determine a female's carrier status one should
order: (Both factor level and genetic testing)

81

72.97%

30

27.03%

12. In an X-linked condition: (50% of the daughters of female
carriers will be carriers)

107

96.40%

4

3.60%

13. Which female family members are obligate carriers?
(Individual II-2 only)

95

85.59%

16

14.41%

14. Which person in this family would be the best candidate to
offer genetic testing? (Individual III-1)

43

38.74%

68

61.26%

7. The chance of a couple having a boy with hemophilia if the
father has hemophilia and the mother is not a carrier is: (None of
the above)
8. An 8 year old boy with hemophilia A comes into clinic with
his mother and 4 year old sister. The sister had a blood test
which revealed a factor level of 60%. What do you tell the
mother about her daughter? (There is no way to know . . .)
9. A boy is diagnosed with severe hemophilia after developing
bleeding symptoms. Genetic testing for this boy revealed an
intron 22 inversion mutation in the F8 gene. The chance that his
mother is a carrier for hemophilia is: (90-100%)
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Table 5: Attitudes toward genetic counseling services, by provider type
Physicians
Statement
1. All mothers of
sons with
hemophilia should
be offered genetic
counseling.
2. All first degree
female relatives of
a patient with
hemophilia should
be offered genetic
counseling.
3. The majority of
my patients would
decline genetic
counseling if it
were offered to
them.
4. I commonly
refer patients for
genetic counseling.
5. In special
circumstances I
refer patients for
genetic counseling.
6. I only refer
patients for genetic
counseling when
they request it.
7. I would feel
comfortable
explaining the
benefits and
limitations of
genetic testing for
hemophilia.
8. I feel
comfortable
educating a patient
about X-linked
inheritance.
9. My patients
would benefit from
meeting with a
genetic counselor.
10. My HTC would
benefit from
having a genetic
counselor on staff.

Nurses

Pvalue

Disagree

Agree

Strongly
Agree

3

2

45

4

9

47

0.164

3

2

45

5

8

47

0.217

44

3

4

43

11

6

0.119

11

9

31

16

22

22

0.027

10

8

33

12

14

31

0.534

39

4

6

49

5

5

0.875

2

14

34

10

18

31

0.067

3

3

45

4

8

48

0.464

5

8

38

1

13

45

0.163

5

8

37

4

17

36

0.230

Disagree

Agree

Strongly
Agree
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Table 6: Confidence in ability to provide genetic counseling services, by provider type
Physicians
Statement
11. Discuss
the risks and
benefits of
being tested
for hemophilia
12. Help a
patient
understand the
possible
implications/u
se of a
positive test
result
13. Discuss
possible
insurance
implications
of having
genetic testing
for hemophilia
14. Help a
patient decide
whether to be
tested
15. Help the
patient cope
with a positive
test result
16. Discuss
the patient's
fears and
concerns
about having a
child with
hemophilia
17. Discuss
the risks and
benefits of
being tested
for hemophilia
18. Help a
patient
understand the
possible
implications/u
se of a
positive test
result
19. Help a
patient decide
whether to be
tested
20. Discuss
the meaning
and
implications
for patients of
a negative test
result

Not
confident

Neither

3

Nurses
P-value

Confident

Not
confident

Neither

Confident

1

47

5

5

48

0.291

3

2

46

6

4

48

0.586

8

11

32

22

13

24

0.026

3

5

43

5

15

38

0.063

2

4

44

3

5

51

1.000

2

2

46

1

4

53

0.653

2

3

45

3

4

52

1.000

2

2

45

1

8

50

0.221

2

4

41

4

10

45

0.349

2

3

45

3

6

50

0.752
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Table 7: Access to Genetic Counseling Services
Access
Access to Genetic Counseling
Services

Physicians

Nurses

Combined

n

%

n

%

n

%

Yes

45

91.84%

53

91.38%

98

91.59%

No

4

8.16%

5

8.62%

9

8.41%

15

33.33%

9

16.98%

24

24.49%

Genetic counselor available by
phone as needed

2

4.44%

2

3.77%

4

4.08%

Genetic counselor available by
referral to an outside institution
Genetic counselor available to
meet with patient at your clinic as
needed

2

4.44%

6

11.32%

8

8.16%

14

31.11%

20

37.74%

34

34.69%

12

26.67%

16

30.19%

28

28.57%

Type of Access
Genetic counselor attends every
clinic

Other
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